Preoperative surgeon evaluation of corneal endothelial status: The Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol

introduction the success of keratoplasty strongly depends on the health status of the transplanted endothelial cells. donor corneal tissues are routinely screened for endothelial damage before shipment; however, surgical teams have currently no means of assessing the overall viability of corneal endothelium immediately prior to transplantation. the aim of this study is to validate a preoperative method of evaluating the endothelial health of donor corneal tissues, to assess the proportion of tissues deemed suitable for transplantation by the surgeons and to prospectively record the clinical outcomes of a cohort of patients undergoing keratoplasty in relation to preoperatively defined endothelial viability. methods and analysis In this multicentre cohort study, consecutive patients undergoing keratoplasty (perforating keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), ultra-thin DSAEK (UT-DSAEK) or descemet membrane endothelial keratoplasty) will be enrolled and followed-up for 1 year. Before transplantation, the endothelial viability of the donor corneal tissue will be evaluated preoperatively through trypan blue staining and custom image analysis to estimate the overall percentage of trypan blue-positive areas (TBPAs), a proxy of endothelial damage. functional and structural outcomes at the end of the follow-up will be correlated with preoperatively assessed TBPA values. ethics and dissemination the protocol will be reviewed by the ethical committees of participating centres, with the sponsor centre issuing the final definitive approval. the results will be disseminated on clinical trials.gov, at national and international conferences, by partner patient groups and in open access, peer-reviewed journals. trial registration number NCT05847387.